Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 11/21/2024Merck's Belzutifan Approved in China for VHL Disease-Associated Tumors
  • 11/21/2024Pfizer and Zai Lab Announce Strategic Deal on Antibacterial Drug XACDU...
  • 11/21/2024CStone and Pharmalink Enter into Strategic Partnership for Sugemalimab...
  • 11/20/2024China-U.S. Health Experts Convene in Beijing to Address Cancer and Chr...
  • 11/20/2024Eli Lilly Partners with Laekna to Develop Next-Generation Obesity Drug...
  • 11/20/2024J&J and Merck Restructure Operations in China Amid Market Challenges
  • 11/20/2024FDA Issues Warning to Tianjin Darentang for Manufacturing and Transpar...
  • 11/19/2024China Grants Priority Review to Ascentage Pharma's Lisaftoclax NDA
  • 11/19/2024Congress Debates Biosecure Act Amid Report Highlighting Misaligned Foc...
  • 11/19/2024NMPA Annouces Adoption of ICH Guideline E11A for Pediatric Extrapolati...
  • 11/18/2024CDE Issues the Technical Guidelines for Clinical Pharmacology Research...
  • 11/18/2024China's Biopharma Boom: A Surge in Innovation and Drug Approvals
  • 11/18/2024HCW Bio and WY Bio Enter License and Co-Development Deal
  • 11/18/2024New Report on China's Biopharma Revolution: A Decade of Progress and t...
  • 11/18/2024ITabMed Unveils Promising Clinical Data on BsAb A-319 for Severe Refra...
  • 11/18/2024LeadingTac Secures CNY100M+ in Series A Financing to Advance TPD-Based...
  • 11/18/2024FDA Grants BTD to Huahui Health's Libevitug (HH-003) for Chronic HDV I...
  • 11/18/2024Avenzo Inks $800 Million Deal for VelaVigo's Nectin-4/TROP2 Bispecific...
  • 11/18/2024Novo Nordisk Launches Weight Loss Drug Wegovy in China
  • 11/18/2024Biosion Announces Global License Deal with Aclaris on Two Potential FI...
  • 11/18/2024Rona Therapeutics Unveils Promising Phase 1 Results for RNA-Based Chol...
  • 11/18/2024CDE Issues the Guidelines for Application of Disease Registry-Based Re...
  • 11/18/2024Merck KGaA and Abbisko's Pimicotinib Shows Promise in Treating Rare Jo...
  • 11/18/2024IMPACT Thera Raises $34M in Series D++ Funding to Advance PARP Inhibit...
  • 11/18/2024C Ray Thera Secures Over $100M to Advance Radiopharma Innovations
  • 11/18/2024WuXi AppTec Opens New R&D Center in Changzhou
  • 11/18/2024Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripal...
  • 11/18/2024Chengdu Keymed Licenses BCMAxCD3 Bispecific Antibody to Platina Medici...
  • 11/15/2024Recent Executive Moves
  • 11/15/2024NMPA Issues the Interim Rules on Designated Domestic Representatives f...
  • Page:9/42 Total number of articles:1234: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group